Clinical Monitoring of Endothelial Dysfunction for Pregnant Women and in the Perioperative Course
Clinical Monitoring of Endothelial Dysfunction for Pregnant Women and in the Perioperative Course - a Pilot Study
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Contatti e Sedi
Luoghi di studio
-
-
-
Berlin, Germania, 13353
- Department of Anesthesiology and Intensive Care Medicine, Campus Virchow Klinikum, Charité - Universitaetsmedizin
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Offered patient information and written informed consent
Female patients aged greater than or equal to 18 years:
- for reduction of a primary ovarian tumour or recidive of an ovarian tumour
pregnant patients with:
- clinical normal pregnancy
- pregnancy with weight gain of more than 10 kg
- pregnancy and gestosis
- healthy volunteers
Exclusion Criteria:
- Persons without the capacity to consent
- Unability of German language use
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- (Unclear) history of alcohol or substances disabuse
- Coworker of the Charité
- Advanced disease of the oesophagus or upper respiratory tract
- Operation in the area of the oesophagus or nasopharynx within the last two months
- Neurological or psychiatric disease
- CHF (congestive heart failure) according to (New York Heart Association) classification - NYHA class IV at the beginning of hospital stay
- American Society of Anaesthesiologists (ASA) classification greater than IV
- Renal insufficiency (dependency of haemodialysis)
- Pulmonal oedema in thorax x-ray
- History of intracranial hemorrhage within one year of participation in the study
- Conditions following venous thrombosis within the last three years before study inclusion
- Inflammatory or reflective disease of blood vessels (Raynaud-Syndrome, Vasculitis)
- Inherent connective tissue disease(e.g. Marfan Syndrome)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
|---|
|
Perioperative ovarian cancer patients
|
|
Pregnant patients
|
|
Female healthy volunteers
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Filtration coefficient
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
Endothelial parameter from the examination with venous occlusion plethysmography.
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
Filtration coefficient
Lasso di tempo: up to one hour single measurement in pregnant woman
|
Endothelial parameter from the examination with venous occlusion plethysmography.
|
up to one hour single measurement in pregnant woman
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
All patients: Hemodynamic parameters
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
|
All patients: Markers of endothelial dysfunction (ICAM-1, E-Selectin, vWF)
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
|
All patients: Endothelial flow-mediated vasodilatation
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
|
Perioperative patients: Blood loss
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
|
Perioperative patients: Parameter of monitored sedation (BIS - Monitoring)
Lasso di tempo: during the operation
|
during the operation
|
|
|
Perioperative patients: Incidence and impact of organ dysfunctions
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
|
Perioperative patients: Pain
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
Patient self-assessed postoperative pain levels during rest using an unmarked zero to one hundred mm visual analog scale (VAS)
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
Perioperative patients: Body weight
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
|
Perioperative patients: Satisfaction of the patients, surgeon and anesthesiologist
Lasso di tempo: on the day of surgery
|
on the day of surgery
|
|
|
Perioperative patients: Duration until clinical discharge criteria were satisfied
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
Postanesthesia Discharge Scoring System (PADS) for Determining Home-Readiness
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
Perioperative patients: Intensive care unit average length of stay; hospital average length of stay
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
|
|
Perioperative patients: Quality of life
Lasso di tempo: perioperatively up to hospital discharge in patients undergoing surgery, an expexcted average of two weeks
|
Descriptive system of health-related quality of life states consisting of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) each of which can take one of three responses.
The responses record three levels of severity (no problems/some or moderate problems/extreme problems) within a particular EQ-5D dimension.
|
perioperatively up to hospital discharge in patients undergoing surgery, an expexcted average of two weeks
|
|
Pregnant patients: History data of the pregnancy, parameter of Gestosis
Lasso di tempo: up to one hour single measurement in pregnant woman
|
Gestosis: toxemia of pregnancy
|
up to one hour single measurement in pregnant woman
|
|
All patients: Immunological Markers
Lasso di tempo: perioperatively up to the fifth postoperative day in patients undergoing surgery
|
Differences in selected immunologic parameters among others IL-6, IL-10
|
perioperatively up to the fifth postoperative day in patients undergoing surgery
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- POPEYE
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .